| Company Name: |
Tianjin Kailiqi Biotechnology Co., Ltd.
|
| Tel: |
15076683720 |
| Email: |
klq@cw-bio.com |
| Products Intro: |
Product Name:SARS-CoV-2 nsp13-IN-1 CAS:1005304-44-8 Purity:大于98% Package:1g,5g,10g,25g根据客户需要分装 Remarks:Not For Human Use, Lab Use Only.
|
| Company Name: |
Jinan Jiuli Biotechnology Co. , Ltd.
|
| Tel: |
15865264761 |
| Email: |
486064515@qq.com |
| Products Intro: |
Product Name:SARS-CoV-2 nsp13-IN-1 CAS:1005304-44-8 Purity:98% Package:500mg;1g;5g
|
| Company Name: |
Bide Pharmatech Ltd.
|
| Tel: |
400-1647117 13681763483 |
| Email: |
product02@bidepharm.com |
| Products Intro: |
Product Name:N-(4-(2-Methyl-4-oxopyrido[2,3-d]pyrimidin-3(4H)-yl)phenyl)-[1,1'-biphenyl]-4-carboxamide CAS:1005304-44-8 Purity:99% Package:10mg;25mg;50mg;100mg;250mg Remarks:BD01578638
|
N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3-yl)phenyl]-4-phenylbenzamide manufacturers
- SARS-CoV-2 nsp13-IN-1
-
- $39.00 / 1mg
-
2025-11-09
- CAS:1005304-44-8
- Min. Order:
- Purity: 99.44%
- Supply Ability: 10g
|
| | N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3-yl)phenyl]-4-phenylbenzamide Basic information |
| Product Name: | N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3-yl)phenyl]-4-phenylbenzamide | | Synonyms: | N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3-yl)phenyl]-4-phenylbenzamide;SARS-CoV-2 nsp13-IN-1;[1,1'-Biphenyl]-4-carboxamide, N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3(4H)-yl)phenyl]-;N-(4-(2-Methyl-4-oxopyrido[2,3-d]pyrimidin-3(4H)-yl)phenyl)-[1,1'-biphenyl]-4-carboxamide;N-(4-(2-Methyl-4-oxopyrido[2,3-d]pyrimidin-3(4H)-yl)phenyl)-[1,1'-biphenyl]-4-carboxamide | | CAS: | 1005304-44-8 | | MF: | C27H20N4O2 | | MW: | 432.47 | | EINECS: | | | Product Categories: | | | Mol File: | 1005304-44-8.mol | ![N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3-yl)phenyl]-4-phenylbenzamide Structure](CAS/20180527/GIF/1005304-44-8.gif) |
| | N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3-yl)phenyl]-4-phenylbenzamide Chemical Properties |
| density | 1.26±0.1 g/cm3(Predicted) | | pka | 12.68±0.70(Predicted) | | form | Solid | | color | White to off-white |
| | N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3-yl)phenyl]-4-phenylbenzamide Usage And Synthesis |
| Uses | SARS-CoV-2 nsp13-IN-1 (compound C1) is a potent nsp13 (non-structural protein 13) inhibitor. SARS-CoV-2 nsp13-IN-1 only inhibits nsp13 ssDNA+ ATPase, with an IC50 of 6 μM. SARS-CoV-2 nsp13-IN-1 does not inhibit ssDNA- ATPase. SARS-CoV-2 nsp13-IN-1 can be used for COVID-19 research[1]. | | References | [1] Yazdi AK, et al. Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors. ACS Infect Dis. 2022 Jul 13. DOI:10.1021/acsinfecdis.2c00165 |
| | N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3-yl)phenyl]-4-phenylbenzamide Preparation Products And Raw materials |
|